Search
NextCure Inc
NXTCAdd to Watchlist
6.580USD
+0.300+4.78%
Close 10-14 16:00（ET）
26.78MMarket Cap
LossP/E TTM
NextCure Inc (NXTC) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to NextCure Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
20.000USD+178.55%
NXTC Analyst Recommendation Trends
In the current month, NXTC has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NXTC average Analyst price target in the last month is 20.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
1
1
1
1
1
1
1
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
3
3
3
3
3
NXTC Analyst Rating for Peer Comparison
Updated: Oct 14, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Revolution Medicines Inc
RVMD
9
14
1
0
0
24
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
7
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Financial Forecasting
Based on analysts' estimates, NXTC EPS is projected to reach -1.429 in FY2026Q3, following reported EPS of -2.805 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-2.42
-2.10
-1.93
-1.43
-1.41
Actual
-2.37
-1.87
-2.80
--
--
Surprise
+1.93%
+11.09%
-45.14%
--
--
FAQs
What is NextCure Inc's price target?
Analysts forecast that NextCure Inc's price target is USD 20.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 20.00.
How have NextCure IncNXTC's recent earnings per share performed?
The market expectation was USD -2.80, while NextCure IncNXTC's earnings per share (EPS) for the previous quarter was USD -1.87. EPS for the next quarter is expected at USD -1.43.
What is the analyst rating for NextCure Inc?
Based on the ratings of NextCure Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.